October 22, 2024
So, how’s that CGM thing going?
With Dexcom reporting earnings Thursday afternoon now as good a time as any to look at the competitive landscape beyond Abbott. Both Dexcom and Abbott have publicly acknowledge at some point there will be a third even fourth credible player in the CGM market. We say credible as there are so many CGM wannabes who haven’t a clue it’s critical to separate the fakes from the companies that just might make it.
We would say that Medtronic is a credible possibility but that’s only partially true. Yes, they have built an FDA approved sensor that . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
